Virtual Meeting to be held on September 24 hosted by Cantor Fitzgerald.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORIC:
- Oric Pharmaceuticals assumed with a Buy at Guggenheim
- Oric Pharmaceuticals’ ORIC-944: A Promising PRC2 Inhibitor with Strategic Partnerships and Market Potential
- ORIC Pharmaceuticals Reports Q2 2025 Financial Results
- Oric Pharmaceuticals appoints Kevin Brodbeck CTO
- Oric Pharmaceuticals: Promising Future with Key Trials and Financial Stability Underpinning Buy Rating